Добірка наукової літератури з теми "Direct cardiac reprogramming"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Direct cardiac reprogramming".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Direct cardiac reprogramming":
Qian, Li, and Deepak Srivastava. "Direct Cardiac Reprogramming." Circulation Research 113, no. 7 (September 13, 2013): 915–21. http://dx.doi.org/10.1161/circresaha.112.300625.
Sadahiro, Taketaro, Shinya Yamanaka, and Masaki Ieda. "Direct Cardiac Reprogramming." Circulation Research 116, no. 8 (April 10, 2015): 1378–91. http://dx.doi.org/10.1161/circresaha.116.305374.
Bruneau, Benoit G. "Direct Reprogramming for Cardiac Regeneration." Circulation Research 110, no. 11 (May 25, 2012): 1392–94. http://dx.doi.org/10.1161/circresaha.112.270637.
Chen, Olivia, and Li Qian. "Direct Cardiac Reprogramming: Advances in Cardiac Regeneration." BioMed Research International 2015 (2015): 1–8. http://dx.doi.org/10.1155/2015/580406.
Kim, Junyeop, Yujung Chang, Yerim Hwang, Sumin Kim, Yu-Kyoung Oh, and Jongpil Kim. "Graphene Nanosheets Mediate Efficient Direct Reprogramming into Induced Cardiomyocytes." Journal of Biomedical Nanotechnology 18, no. 9 (September 1, 2022): 2171–82. http://dx.doi.org/10.1166/jbn.2022.3416.
Zhang, Zhentao, Jesse Villalpando, Wenhui Zhang, and Young-Jae Nam. "Chamber-Specific Protein Expression during Direct Cardiac Reprogramming." Cells 10, no. 6 (June 16, 2021): 1513. http://dx.doi.org/10.3390/cells10061513.
Sadahiro, Taketaro. "Direct Cardiac Reprogramming ― Converting Cardiac Fibroblasts to Cardiomyocytes ―." Circulation Reports 1, no. 12 (December 10, 2019): 564–67. http://dx.doi.org/10.1253/circrep.cr-19-0104.
Ieda, Masaki. "Direct cardiac reprogramming by defined factors." Inflammation and Regeneration 33, no. 4 (2013): 190–96. http://dx.doi.org/10.2492/inflammregen.33.190.
Engel, James L., and Reza Ardehali. "Direct Cardiac Reprogramming: Progress and Promise." Stem Cells International 2018 (2018): 1–10. http://dx.doi.org/10.1155/2018/1435746.
Kurotsu, Shota, Takeshi Suzuki, and Masaki Ieda. "Mechanical stress regulates cardiac direct reprogramming." Proceedings for Annual Meeting of The Japanese Pharmacological Society WCP2018 (2018): OR15–1. http://dx.doi.org/10.1254/jpssuppl.wcp2018.0_or15-1.
Дисертації з теми "Direct cardiac reprogramming":
Bachamanda, Somesh Dipthi [Verfasser]. "Induced cardiomyocyte precursor cells obtained by direct reprogramming of cardiac fibroblasts / Dipthi Bachamanda Somesh." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2020. http://d-nb.info/1223925676/34.
Elkhoury, Kamil. "Nanofunctionalization and biofabrication of natural hydrogels for tissue engineering applications." Electronic Thesis or Diss., Université de Lorraine, 2021. http://www.theses.fr/2021LORR0020.
The main objective of this thesis is to develop a new natural material based on methacrylated gelatin (GelMA) nanofunctionalized by the incorporation of nanoliposomes or soft hybrid exosome-liposome nanoparticles. The physicochemical and biological properties of these hydrogel matrices were characterized in order to evaluate their potential use for tissue engineering applications. GelMA is prepared by the chemical modification of gelatin when methacrylate groups are attached to side groups containing amine functions. In a first part of this work, the influence of the gelatin source (pork or fish) and the degree of methacrylation on the physicochemical and biological properties of hydrogels was studied. In a second part of this work, the GelMA matrix was nanofunctionalized by the incorporation of nanoliposomes, which are soft and natural nanoparticles with remarkable self-assembly properties. These well-established drug delivery systems are formed of lipid bilayers and can transport and release hydrophobic, hydrophilic, and amphiphilic molecules. In this study, naringin, an active molecule that can guide the differentiation process of stem cells to the osteoblastic lineage, was encapsulated in nanoliposomes before their incorporation into the GelMA polymeric matrix in order to develop a system of interest for bone regeneration applications. This nanocomposite material was physicochemically and biologically characterized and the release profile of naringin was investigated. In a third and final part of this work, the GelMA matrix was nanofunctionalized by the incorporation of exosome-liposome soft hybrid nanoparticles. Exosomes, natural nanovesicles secreted by cells, are of increasing interest for targeted drug delivery applications due to the presence of cell specific receptors on their surface. The hybrid GelMA hydrogels were physicochemically and biologically characterized for applications in cardiac reprogramming and was successfully bioprinted and microfabricated. Biofabricated GelMA hydrogels nanofunctionalized with nanoliposomes or hybrid exosome-liposome nanoparticles are promising platforms for the controlled release of bioactive molecules and for tissue engineering applications
Частини книг з теми "Direct cardiac reprogramming":
Haginiwa, Sho, and Masaki Ieda. "Direct Cardiac Reprogramming." In Cardiac and Vascular Biology, 123–43. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56106-6_6.
Liu, Dingqian, Khawaja Husnain Haider, and Changfa Guo. "Bioengineering Technique Progress of Direct Cardiac Reprogramming." In Handbook of Stem Cell Therapy, 1333–65. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-2655-6_27.
Jayawardena, Tilanthi, Maria Mirotsou, and Victor J. Dzau. "Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes Using MicroRNAs." In Methods in Molecular Biology, 263–72. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0512-6_18.
Paoletti, Camilla, Carla Divieto, and Valeria Chiono. "Direct Reprogramming of Adult Human Cardiac Fibroblasts into Induced Cardiomyocytes Using miRcombo." In Methods in Molecular Biology, 31–40. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2707-5_3.
Ma, Hong, Li Wang, Jiandong Liu, and Li Qian. "Direct Cardiac Reprogramming as a Novel Therapeutic Strategy for Treatment of Myocardial Infarction." In Methods in Molecular Biology, 69–88. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-6588-5_5.
Paoletti, Camilla, Carla Divieto, and Valeria Chiono. "Correction to: Direct Reprogramming of Adult Human Cardiac Fibroblasts into Induced Cardiomyocytes Using miRcombo." In Methods in Molecular Biology, C1. New York, NY: Springer US, 2023. http://dx.doi.org/10.1007/978-1-0716-2707-5_27.
Jain, Pooja, Nazia Hassan, Uzma Farooq, and Zeenat Iqbal. "Nanotechnology-Based Direct Cardiac Reprogramming for Cardiac Regeneration." In Nanomedicinal Approaches Towards Cardiovascular Disease, 106–24. BENTHAM SCIENCE PUBLISHERS, 2021. http://dx.doi.org/10.2174/9789814998215121010015.
Haridhasapavalan, Krishna Kumar, Atreyee Borthakur, and Rajkumar P. Thummer. "Direct Cardiac Reprogramming: Current Status and Future Prospects." In Advances in Experimental Medicine and Biology. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/5584_2022_760.
Тези доповідей конференцій з теми "Direct cardiac reprogramming":
Klose, K., M. Gossen, and C. Stamm. "Direct Genetic and/or Pharmacologic Reprogramming for Creation of Cardiomyocytes: Is It Real?" In 48th Annual Meeting German Society for Thoracic, Cardiac, and Vascular Surgery. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1678823.